GleamWall
中文EN

EHC Encompass Health Corp

Services-Hospitals · NYSE · SEC CIK 785161 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY9.4%
TTM net income YoY19.1%
TTM EPS YoY21.0%
Revenue 3-yr CAGR10.5%
Net income 3-yr CAGR22.1%

Margins

Gross margin—
Operating margin—
Net margin10.2%
FCF margin7.2%
EBITDA margin—

Returns

ROE25.5%
ROA8.9%
ROIC (approx.)—
Asset turnover0.88x

Leverage & solvency

Liabilities / assets52.9%
Debt / equity0.97x
Current ratio1.09x
Interest coverage—

Cash quality & payout

Operating cash flow / net income2.02x
Accruals ratio-9.1%
Payout ratio11.9%
Capex / revenue13.4%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$1.61B$1.60B$1.59B$1.54B$1.48B$1.46B$1.46B$1.41B
SG&A expense$59.90M$62.60M$58.20M$68.40M$56.10M$59.40M$52.30M$54.50M
Interest expense$32.20M$32.80M$31.80M$30.20M$30.80M$30.40M$31.80M$33.00M
Pretax income$257.80M$261.60M$288.70M$257.70M$219.90M$236.80M$238.60M$201.40M
Income tax$53.40M$53.60M$56.40M$55.40M$44.90M$51.00M$41.60M$37.60M
Net income$149.90M$153.90M$194.50M$146.10M$126.50M$142.10M$151.50M$120.90M
EPS (basic)1.521.551.96—1.261.411.50—
EPS (diluted)1.501.541.93—1.241.391.48—
Dividends declared per share0.210.190.190.190.190.170.170.17
Weighted avg. shares (diluted)99.70M100.00M100.60M—102.30M102.30M102.10M—
Balance sheet
Cash & equivalents$76.20M$107.70M$110.50M$72.20M$48.70M$99.10M$95.80M$85.40M
Receivables$712.00M$687.30M$676.00M$619.20M$610.80M$612.50M$623.40M$593.00M
Current assets$1.01B$1.04B$1.03B$905.90M$869.80M$918.10M$910.90M$886.90M
PP&E, net$4.48B$4.34B$4.22B$4.10B$3.93B$3.82B$3.72B$3.64B
Goodwill$1.32B$1.32B$1.32B$1.32B$1.30B$1.30B$1.28B$1.28B
Intangibles$301.50M$306.80M$300.30M$308.30M$291.90M$295.90M$294.50M$297.80M
Total assets$7.57B$7.46B$7.31B$7.09B$6.87B$6.79B$6.64B$6.53B
Current liabilities$927.40M$873.40M$876.80M$836.40M$762.00M$865.10M$856.00M$841.00M
Short-term debt$47.80M$35.90M$42.90M$43.60M$39.00M$139.20M$138.70M$138.60M
Long-term debt$2.55B$2.60B$2.53B$2.45B$2.39B$2.32B$2.33B$2.36B
Total debt$2.60B$2.63B$2.57B$2.49B$2.43B$2.46B$2.47B$2.50B
Total liabilities$4.01B$4.00B$3.95B$3.81B$3.68B$3.70B$3.70B$3.69B
Shareholders' equity$2.68B$2.60B$2.52B$2.44B$2.37B$2.28B$2.16B$2.07B
Net debt$2.52B$2.53B$2.46B$2.42B$2.38B$2.36B$2.38B$2.41B
Cash flow statement
Operating cash flow$362.00M$282.60M$313.10M$346.00M$270.80M$270.20M$288.60M$278.80M
Capital expenditure$234.50M$220.30M$162.40M$229.30M$187.10M$156.90M$163.10M$198.70M
Free cash flow$127.50M$62.30M$150.70M$116.70M$83.70M$113.30M$125.50M$80.10M
Investing cash flow-$241.60M-$235.60M-$150.10M-$239.40M-$201.30M-$165.40M-$158.50M-$203.70M
Financing cash flow-$153.70M-$76.90M-$102.50M-$97.40M-$113.20M-$90.20M-$130.40M-$150.90M
Depreciation & amortization$95.70M$90.40M$87.30M$86.40M$82.40M$79.90M$79.20M$78.00M
Stock-based compensation$15.00M$13.80M$11.50M$18.40M$14.30M$14.30M$9.50M$12.50M
Dividends paid$18.70M$18.90M$20.30M$19.00M$17.00M$17.10M$18.00M$17.00M
Share buybacks$57.90M$74.20M$71.60M$76.30M$24.90M$24.70M$32.10M$7.50M

Free plan shows the latest 8 periods; Pro shows all 70 🔒

· This company does not report gross profit in XBRL.

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.